ASP-II: Ancrod Stroke Program: Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke

Update Il y a 4 ans
Reference: NCT00300196

Woman and Man

Extract

The primary purpose of this study is to determine whether a brief intravenous infusion of ancrod started within 6 hours of stroke onset improves functional outcome at 3 months.


Inclusion criteria

  • Stroke ,Cerebral Ischemia ,Brain Infarction


Links